SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of $240.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2025-02-26
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2023 was $240.00K, a 245.52% increase from fiscal 2022.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2022 was $69.46K.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month as first filed |
|---|---|---|
| 2023-12-31 | $240.00K 10-K · filed 2025-02-26 | -$240.00K 10-K · filed 2024-03-21 |
| 2022-12-31 | $69.46K 10-K/A · filed 2024-09-04 | -$83.97K 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |